Cargando…

Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine?

BACKGROUND: Using serum creatinine leads to an overestimation of kidney function in patients with primary neuromuscular disorders, and reduced kidney function may remain undetected. Cystatin C (CysC) could provide a better estimation. AIM: To evaluate the precision, accuracy, and bias of two creatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldenbratt, Annika, Lindberg, Christopher, Johannesson, Elias, Hammarsten, Ola, Svensson, Maria K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926948/
https://www.ncbi.nlm.nih.gov/pubmed/34351595
http://dx.doi.org/10.1007/s40620-021-01122-x
_version_ 1784670340634378240
author Aldenbratt, Annika
Lindberg, Christopher
Johannesson, Elias
Hammarsten, Ola
Svensson, Maria K.
author_facet Aldenbratt, Annika
Lindberg, Christopher
Johannesson, Elias
Hammarsten, Ola
Svensson, Maria K.
author_sort Aldenbratt, Annika
collection PubMed
description BACKGROUND: Using serum creatinine leads to an overestimation of kidney function in patients with primary neuromuscular disorders, and reduced kidney function may remain undetected. Cystatin C (CysC) could provide a better estimation. AIM: To evaluate the precision, accuracy, and bias of two creatinine-, one cystatin C-based and one combined equation to estimate glomerular filtration rate (eGFR) in patients with primary neuromuscular disease. PATIENTS AND METHODS: Of the 418 patients initially identified at the out-patient clinic, data on kidney function was obtained for 145 adult patients (age 46 ± 14 years, BMI 26 ± 6 kg/m(2)) with primary neuromuscular disease. Kidney function was measured by iohexol clearance, and blood samples for serum creatinine and CysC were drawn simultaneously. Bias was defined as the mean difference between eGFR and measured iohexol clearance, and accuracy as the proportion of eGFRs within ± 10% (P10) of measured clearance. RESULTS: Kidney function (iohexol clearance) was 81 ± 19 (38–134) ml/min/1.73m(2). All equations overestimated kidney function by 22–60 ml/min/1.73m(2). eGFR CysC had the lowest bias overall 22 (95% CI 20–26) ml/min/1.73m(2) also at all levels of kidney function we evaluated (at 30–59 ml/min/1.73m(2) bias was 27 (95% CI 21–35), at 60–89 it was 25 (95% CI 20–28) and at ≥ 90 it was 12 (95% CI 7–22)). eGFR CysC also had the best accuracy in patients with reduced kidney function (P10 was 5.9% at 30–59 ml/min/1.73m(2)). CONCLUSIONS: Cystatin C-based estimations of kidney function performed better than creatinine-based ones in patients with primary neuromuscular disease, but most importantly, all evaluated equations overestimated kidney function, especially in patients with reduced kidney function. Therefore, kidney function should be measured by gold-standard methods when precision and accuracy are needed. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40620-021-01122-x.
format Online
Article
Text
id pubmed-8926948
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-89269482022-03-22 Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine? Aldenbratt, Annika Lindberg, Christopher Johannesson, Elias Hammarsten, Ola Svensson, Maria K. J Nephrol Original Article BACKGROUND: Using serum creatinine leads to an overestimation of kidney function in patients with primary neuromuscular disorders, and reduced kidney function may remain undetected. Cystatin C (CysC) could provide a better estimation. AIM: To evaluate the precision, accuracy, and bias of two creatinine-, one cystatin C-based and one combined equation to estimate glomerular filtration rate (eGFR) in patients with primary neuromuscular disease. PATIENTS AND METHODS: Of the 418 patients initially identified at the out-patient clinic, data on kidney function was obtained for 145 adult patients (age 46 ± 14 years, BMI 26 ± 6 kg/m(2)) with primary neuromuscular disease. Kidney function was measured by iohexol clearance, and blood samples for serum creatinine and CysC were drawn simultaneously. Bias was defined as the mean difference between eGFR and measured iohexol clearance, and accuracy as the proportion of eGFRs within ± 10% (P10) of measured clearance. RESULTS: Kidney function (iohexol clearance) was 81 ± 19 (38–134) ml/min/1.73m(2). All equations overestimated kidney function by 22–60 ml/min/1.73m(2). eGFR CysC had the lowest bias overall 22 (95% CI 20–26) ml/min/1.73m(2) also at all levels of kidney function we evaluated (at 30–59 ml/min/1.73m(2) bias was 27 (95% CI 21–35), at 60–89 it was 25 (95% CI 20–28) and at ≥ 90 it was 12 (95% CI 7–22)). eGFR CysC also had the best accuracy in patients with reduced kidney function (P10 was 5.9% at 30–59 ml/min/1.73m(2)). CONCLUSIONS: Cystatin C-based estimations of kidney function performed better than creatinine-based ones in patients with primary neuromuscular disease, but most importantly, all evaluated equations overestimated kidney function, especially in patients with reduced kidney function. Therefore, kidney function should be measured by gold-standard methods when precision and accuracy are needed. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40620-021-01122-x. Springer International Publishing 2021-08-05 2022 /pmc/articles/PMC8926948/ /pubmed/34351595 http://dx.doi.org/10.1007/s40620-021-01122-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Aldenbratt, Annika
Lindberg, Christopher
Johannesson, Elias
Hammarsten, Ola
Svensson, Maria K.
Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine?
title Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine?
title_full Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine?
title_fullStr Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine?
title_full_unstemmed Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine?
title_short Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine?
title_sort estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin c a better marker of kidney function than creatinine?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926948/
https://www.ncbi.nlm.nih.gov/pubmed/34351595
http://dx.doi.org/10.1007/s40620-021-01122-x
work_keys_str_mv AT aldenbrattannika estimationofkidneyfunctioninpatientswithprimaryneuromusculardiseasesisserumcystatincabettermarkerofkidneyfunctionthancreatinine
AT lindbergchristopher estimationofkidneyfunctioninpatientswithprimaryneuromusculardiseasesisserumcystatincabettermarkerofkidneyfunctionthancreatinine
AT johannessonelias estimationofkidneyfunctioninpatientswithprimaryneuromusculardiseasesisserumcystatincabettermarkerofkidneyfunctionthancreatinine
AT hammarstenola estimationofkidneyfunctioninpatientswithprimaryneuromusculardiseasesisserumcystatincabettermarkerofkidneyfunctionthancreatinine
AT svenssonmariak estimationofkidneyfunctioninpatientswithprimaryneuromusculardiseasesisserumcystatincabettermarkerofkidneyfunctionthancreatinine